Furthermore, we explored the clinicopathologic characteristics of RPA1-dependent, ETAA1-mediated events in liver cancer patients by analyzing the correlations between ETAA1 and RPA1 expression levels and liver cancer stages and tumor grades. The gene discussed is RPA1; the disease is neoplasm.